A study of centanafadine for adults with ADHD and emotional symptoms
Part of Mental health clinical trials.
This study tests an investigational medicine called centanafadine for adults with ADHD who also have trouble managing their emotions. The goal is to see if the medicine can help improve both attention and emotional control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult with a formal ADHD diagnosis.
- Your ADHD symptoms must be at least moderate, and you must also have significant emotional symptoms.
- You must not have certain other mental health conditions like bipolar disorder, schizophrenia, or borderline personality disorder.
- You must not currently have major depression, PTSD, substance use disorder, or untreated sleep apnea.
- You must not have tried and failed two or more ADHD medications from different classes during adulthood.
- You must not have taken centanafadine before or participated in another drug trial within the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the medication Dyanavel XR (a long-acting amphetamine) can help reduce fatigue in adults with ADHD. It is for people who have both ADHD and significant tiredness, and who are not currently taking stimulant ADHD drugs.
This trial tests a new extended-release medication called Onyda XR (clonidine) in children aged 6 to 12 who have both ADHD and Oppositional Defiant Disorder. The goal is to see if it helps with symptoms like inattention, hyperactivity, and defiant behavior, and if it is safe.
This trial tests if the medication Foquest can help treat ADHD symptoms in adults aged 65 and older. It aims to see if it's safe and effective for this age group.
This study tests whether N-acetylcysteine (NAC) can help children aged 6 to 12 with emotional dysregulation (severe mood swings, anxiety, or attention problems). It's a non-drug supplement that may improve brain function. The trial also includes a control group of typically developing kids for comparison.
This study tests if Jornay PM, a long-acting ADHD medication, helps control symptoms, focus, and emotions throughout the day and into the early evening in adults with ADHD. It is an open-label study, meaning everyone knows they are getting the medication, and then they are randomly assigned to different observation groups.
This study compares stimulant and non-stimulant ADHD medicines in kids who have not taken ADHD medication before. It also studies how these treatments affect brain “reward” processes, which may be linked to substance-use risk.
Hear when a new ADHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.